These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 9925518)

  • 1. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
    Ephros M; Bitnun A; Shaked P; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1999 Feb; 43(2):278-82. PubMed ID: 9925518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.
    Ephros M; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1997 May; 41(5):1064-8. PubMed ID: 9145870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions.
    Carrió J; de Colmenares M; Riera C; Gállego M; Arboix M; Portús M
    Exp Parasitol; 2000 Jul; 95(3):209-14. PubMed ID: 10964649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.
    Walker J; Saravia NG
    J Parasitol; 2004 Oct; 90(5):1155-62. PubMed ID: 15562618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
    Gebre-Hiwot A; Tadesse G; Croft SL; Frommel D
    Acta Trop; 1992 Aug; 51(3-4):237-45. PubMed ID: 1359751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani.
    Shaked-Mishan P; Ulrich N; Ephros M; Zilberstein D
    J Biol Chem; 2001 Feb; 276(6):3971-6. PubMed ID: 11110784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.
    Sereno D; Cavaleyra M; Zemzoumi K; Maquaire S; Ouaissi A; Lemesre JL
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3097-102. PubMed ID: 9835497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of Leishmania viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA-protein complexes.
    Lucumi A; Robledo S; Gama V; Saravia NG
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1990-5. PubMed ID: 9687395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
    Carrió J; Portús M
    BMC Pharmacol; 2002 May; 2():11. PubMed ID: 12019027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of luciferase expressing Leishmania donovani axenic amastigotes as primary model for in vitro screening of antileishmanial compounds.
    Ravinder ; Bhaskar ; Gangwar S; Goyal N
    Curr Microbiol; 2012 Dec; 65(6):696-700. PubMed ID: 22945482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.
    Vermeersch M; da Luz RI; Toté K; Timmermans JP; Cos P; Maes L
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3855-9. PubMed ID: 19546361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of gene expression in human macrophages treated with the anti-leishmania pentavalent antimonial drug sodium stibogluconate.
    El Fadili K; Imbeault M; Messier N; Roy G; Gourbal B; Bergeron M; Tremblay MJ; Légaré D; Ouellette M
    Antimicrob Agents Chemother; 2008 Feb; 52(2):526-33. PubMed ID: 18070969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum.
    Pujals G; Suñé-Negre JM; Pérez P; García E; Portus M; Tico JR; Miñarro M; Carrió J
    Parasitol Res; 2008 May; 102(6):1243-7. PubMed ID: 18278586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.
    Valiathan R; Dubey ML; Mahajan RC; Malla N
    Exp Parasitol; 2006 Oct; 114(2):103-8. PubMed ID: 16616137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
    Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
    Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran.
    Nateghi-Rostami M; Tasbihi M; Darzi F
    Acta Trop; 2022 Jun; 230():106392. PubMed ID: 35276060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines.
    Ouakad M; Vanaerschot M; Rijal S; Sundar S; Speybroeck N; Kestens L; Boel L; De Doncker S; Maes I; Decuypere S; Dujardin JC
    Parasitology; 2011 Sep; 138(11):1392-9. PubMed ID: 21819638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.
    Gramiccia M; Gradoni L; Orsini S
    Ann Trop Med Parasitol; 1992 Dec; 86(6):613-20. PubMed ID: 1304703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of In vitro and In vivo Drug Efficacy Over Leishmania tropica: A Pilot Study.
    Özbilgin A; Çavuş İ; Yıldırım A; Kaya T; Ertabaklar H
    Turkiye Parazitol Derg; 2018 Mar; 42(1):11-19. PubMed ID: 29780014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.